Want to join the conversation?
$ISRG said on its 1Q16 call, it estimated full year 2016 procedure growth of 12-14% above the approx. 652,000 procedures performed in 2015. The company added that it is increasing its estimate for 2016 and now anticipates full year 2016 procedure growth within a range of 14-15%.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.